Secondaries announced 9.6.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]
